SCHEMBL7365769

SCHEMBL7365769

NCC(=O)N(c1ccccc1)[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALPI P09923 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ XIAP P98170 1/20 0.46
▸ SLC7A5 Q01650 1/20 0.46
▸ CYP1A2 P05177 1/20 0.44
▸ SRR Q9GZT4 2/20 0.42
▸ SLC1A3 P43003 2/20 0.42
▸ SLC1A2 P43004 2/20 0.42
▸ SLC1A1 P43005 2/20 0.42
▸ MDM2 Q00987 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ CTRB1 P17538 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29131646 1.00 ALPI (0.46) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL7370982 0.84 MMP8 (0.47) PKMALDH1A1LMNATP53SMN1; SMN2
SCHEMBL7365185 0.84 CTRB1 (0.43) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL22588881 0.84 ALPI (0.49) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL4456102 0.84 ALDH1A1 (0.42) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL22588878 0.84 ALPI (0.49) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL13358895 0.83 ALDH1A1 (0.41) CTRB1ALDH1A1LMNATP53SMN1; SMN2
SCHEMBL17158366 0.82 ALPI (0.50) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL27277367 0.81 ALPI (0.49) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL7550315 0.81 ALPI (0.49) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001973-A1 COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 — — EP claimed
WO-1999006433-A1 COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 — — WO claimed
EP-1001973-A1 COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 — — EP disclosed
WO-1999006433-A1 COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 — — WO disclosed
Send feedback